Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors

Journal: Nature Communications

Published: 2020-07-24

DOI: 10.1038/s41467-020-17525-6

Affiliations: 13

Authors: 21

Go to article
Institutions Share
Department of Microbiology, Tumor and Cell Biology (MTC), KI, Sweden 0.43
State Key Laboratory of Ophthalmology, SYSU, China 0.14
State Key Laboratory of Experimental Hematology, CAMS & PUMC, China 0.10
Shanghai Shuguang Hospital, China 0.07
Institute of Biomedicine, JNU, China 0.05
Qilu Hospital of Shandong University, China 0.05
Department of Cellular and Genetic Medicine, Fudan University, China 0.02
Graduate School of Medical and Dental Sciences, Kagoshima University, Japan 0.02
Second Hospital of Shandong University, China 0.02
Medicine Research Center, Binzhou Medical University, China 0.02
Department of Medicine, Huddinge (MEDH), KI, Sweden 0.02
Center for Molecular Medicine (CMM), KI, Sweden 0.02
The University of Tokyo Hospital, Japan 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER